1-8 of 8
Chien-Shing Chen, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The New Landscape of Checkpoint Inhibitors in China

Chien-Shing Chen, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5855.
https://doi.org/10.1182/blood-2018-99-111666
Published: 2018
Journal Articles

Novel AML-Associated Loss of Function Mutations in the B55 Alpha Subunit of PP2A Are Associated with Increased Phosphorylation and Activation of AKT and Enhanced Sensitivity to AKT Inhibitor Induced Cell Growth Arrest

Geoffrey P. Shouse, MD PhD, Rosalia de Necochea-Campion, MS, Saied Mirshahidi, PhD, Xuan Liu, MD PhD, Chien-Shing Chen, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2206.
https://doi.org/10.1182/blood.V124.21.2206.2206
Published: 2014
Journal Articles

High Transcription Levels Of S100A8 and S100A9 In Acute Myeloid Leukemia Are Predictors For Poor Overall Survival

Shao-yan Hu, MD, PhD, Ming-ying Zhang, Shui-yan Wu, Dong Wu, Neetika Ashwani, Jian Pan, Ph.D., Hai-long He, Jian-nong Cen, MD, Zi-Xing Chen, MD, Chien-Shing Chen, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2610.
https://doi.org/10.1182/blood.V122.21.2610.2610
Published: 2013
Journal Articles

IGFBP7 Gene Promoting Cell Proliferation in Acute Myeloid Leukemia Through Activation of AKT3 and CCND1

Shaoyan Hu, MD, PhD, Shui-yan Wu, MD, Jian-nong Cen, MD, Jian Pan, Ph.D., Xiaofei Qi, Ph.D., Zixing Chen, MD, Ph.D., Xing Feng, MD, Ph.D., Chien-Shing Chen, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1447.
https://doi.org/10.1182/blood.V120.21.1447.1447
Published: 2012
Journal Articles

C3aR1 Contributed to Acute Myeloid Leukemia Acquired Resistance to ABT-737 and Involved In the Process of AML

Shaoyan Hu, MD, PhD, Saied Mirshahidi, Ph.D., Chong-Lei Bi, B.S., Wee-Joo Chng, MRCP, MRCPath, Heng-Wei Hsu, B.S., Shui-yan Wu, Jian Pan, Jian-nong Cen, Chien-Shing Chen, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 1435.
https://doi.org/10.1182/blood.V118.21.1435.1435
Published: 2011
Journal Articles

Bortezomib In Combination with Rituximab, Cyclophosphamide, and Prednisone with or without Doxorubicin Followed by Rituximab Maintenance In Patients with Relapsed or Refractory Follicular Lymphoma: Results of a Phase 2 Study.

Michael Craig, MD, Wahid T Hanna, MD, Fernando Cabanillas, MD, Chien-Shing Chen, MD, PhD, Sudha Parasuraman, MD, Rachel Neuwirth, MS, Owen A. O'Connor, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2798.
https://doi.org/10.1182/blood.V116.21.2798.2798
Published: 2010
Journal Articles

Identification of Core Gene Signature Associated with Synergism Between ABT-869, a FLT3 Inhibitor and SAHA, a HDAC Inhibitor in AML with FLT3-ITD Mutation.

Jianbiao Zhou, MD, MS, Chonglei Bi, Bsc, Shaw-Cheng Liu, Wee-Joo Chng, MD, Kian-Ghee Tay, Bsc, Hanry Yu, Ph.D., Keith Glaser, Ph.D., Daniel Albert, PhD, BSc, Steven K Davidsen, Ph.D., Chien-Shing Chen, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 1618.
https://doi.org/10.1182/blood.V112.11.1618.1618
Published: 2008
Journal Articles

Merit of Initiating Peripheral Blood Stem Cell (PBSC) Collections at Low Level of Circulating CD34+ Cells.

Ping Law, PhD, Lip Kun Tan, MD, Fathalha Yasir, BS, Teck Guan Soh, BS, Joanna K.Y. Mah, BS, Jenny Li, BS, Te Chih Liu, MD, Chien Shing Chen, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 5262.
https://doi.org/10.1182/blood.V106.11.5262.5262
Published: 2005